/PRNewswire/ The non-insulin diabetes therapeutics market is poised to grow by USD 22.95 billion during 2021-2025, progressing at a CAGR of over 10% during.
/CNW/ - Across Canada, more and more people are getting vaccinated. As of June 5, more than 70% of people 12 years of age and older in Canada have received.
/PRNewswire/ Bridge Biotherapeutics (KQ288330) announced today the first patient dosing of BBT-401 at mid to high doses in its proof of clinical principle.
/PRNewswire/ GENinCode UK Limited, the cardiovascular disease company focused on predictive genetics for the prevention of cardiovascular disease, announces.